StemRNA™ Neuro – Human Neurons


Brand: Stemgent™

Purchase product: USA Store

Product Code Pack Size Price in
The Americas
Price in EMEA
RCDN001N 3 × 10⁶ cells USD $ 700.00 GBP £ 541.93 EUR € 615.10

Prices do not include shipping and handling charges.


A mixed population of brain-like, iPSC-derived human neurons expressing a wide range of neuronal and synaptic markers. Maturation in Neuro Culture Medium or Neuro MQ Culture Medium is required. Vial contents provide enough cells for an entire 96-well plate.

(StemRNA™ Neuro was previously called ReproNeuro.)

Wild-type human brain cell neurons for general purpose assays

Frozen human iPSC-derived neurons for 96-well high throughput and high content assays

  • Frozen as a suspension of individualized neuroprogenitor cells
  • Rapidly differentiate into neurons during in vitro growth and maturation
  • Display measurable neuronal function
  • Form dendritic connections leading to synchronized burst behavior around week 6 in vitro
  • Responsive to various reference compounds that modulate neuron electrophysiology
  • Expresses multiple neuron-specific markers, indicating a mixed population of neuron types
  • Two different culture media are available separately

StemRNA Neuro iPS-derived neurons are cryopreserved using REPROCELL's proprietary cryopreservation technology. Thawed and plated StemRNA Neuro cells mature during 2-3 weeks of culture on surfaces treated with Neuro Coat (RCDN201).

Types of ReproNeuro Media

Note that one of the following media is required for proper maturation of the StemRNA Neuro cells:

  • Neuro Culture Medium (RCDN101); standard medium for general purpose assays
  • Neuro MQ Culture Medium (RCDN102); a specialty medium formulated with rat astrocyte supplementation resulting in maximum performance in MEA (multiple electrode array) assays



  • Society for Biomolecular Sciences (SBS), 14th AnnualConference and Exhibition 2008 (St. Louis), poster session, April 2008.
  • IBC Asia's 4th Annual Stem Cells Asia Congress (Singapore), oral session, June 2008.
  • ELRIG and SBS Present: Drug Discovery (UK) poster session, September 2008.
  • Advances in Stem Cell Discoveries (San Francisco) oral session, September 2008.
  • Stem Cells: Drug Discovery and Therapeutics (London) oral session, February 2008.
  • Society for Biomolecular Science 15th Annual Conference (France), poster session, Best Poster 2009 Award-winning, April 2009.
  • Stem Cells and Regenerative Medicine Europe (UK), September 2009, Best Poster 2009 Award-winning.
  • MipTec Conference 2009, October 13-15, Basel Invited Lecture.
  • The 74th Annual Scientific Meeting of the Japanese Circulation Society (Kyoto), March 2010.
  • The 130th The Pharmaceutical Society of Japan (Okayama), March 2010.
  • The Society of Toxicology (SOT) 51st Annual Meeting (CA, USA), poster session, March 2012.
  • Safety Pharmacology Society (SPS), 13th annual meeting 2013 (Rotterdam, Netherlands), poster session, September 2013.
  • Automated Patch-Clamp systems and Ion Channel Expressing Cells 2013 (Tokyo), Verbal presentation 2013 Nov.
  • The 7th Takeda Science Foundation Symposium (Osaka), Poster presentation 2014 Jan.